Articles From: Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases to DDR Provides 2015 Operating FFO Guidance


- Trial results show novel S1P1 modulator produced strong, dose-dependent lymphocyte lowering - - No clinically significant safety findings relative to heart, liver or pulmonary function - SAN DIEGO , Jan.
Sign-up for Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases investment picks
CAMBRIDGE, Mass., Jan.
Sign-up for Merrimack Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
Amber Road, Inc. (NYSE: AMBR), a leading provider of global trade management (GTM) solutions, today announced that Chief Executive Officer, Jim Preuninger, and Chief Financial Officer, Thomas Conway, will present at the Needham Growth Conference in New York City on January 13, 2015 at 2:50 p.m. ET.
Sign-up for Amber Road to Present at the Needham Growth Conference investment picks
BRANFORD, Conn., Jan.
Sign-up for CASMED Reports Preliminary Sales for the 2014 Fourth Quarter and Full Year investment picks
Ares Management, L.P. (NYSE:ARES) announced today the final closings of two real estate funds, both of which were significantly oversubscribed.
Sign-up for Ares Management Closes Two Oversubscribed Real Estate Funds investment picks
Cerus Corporation (NASDAQ:CERS) today announced the pricing of an underwritten public offering of 12,727,273 shares of its common stock, offered at a price to the public of $5.50 per share for expected gross proceeds of $70.0 million.
Sign-up for Cerus Prices $70.0 Million Public Offering of Common Stock investment picks
Advanced cableless solution detects fetal heart rate and maternal pulse allowing beneficial freedom of movement during labor ANDOVER, Mass.
Sign-up for Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution investment picks
SunCoke Energy, Inc. (NYSE: SXC) today reported preliminary fourth quarter 2014 domestic coke production of 1,083 thousand tons, up approximately 27 thousand tons versus fourth quarter 2013, primarily due to production improvements and better coal-to-coke yields at our Indiana Harbor facility.
Sign-up for SunCoke Energy, Inc. Domestic Coke Production Estimated to Be 1,083 Thousand Tons in Fourth Quarter 2014 investment picks
SunCoke Energy Partners, L.P. (NYSE: SXCP) today reported preliminary fourth quarter 2014 coke production at its Haverhill and Middletown facilities of 452 thousand tons up slightly from 445 thousand tons in fourth quarter 2013.
Sign-up for SunCoke Energy Partners, L.P. Coke Production Estimated to Be 452 Thousand Tons in Fourth Quarter 2014 investment picks
MONTVALE, N.J. , Jan.
Sign-up for AEP Industries Inc. Schedules Conference Call to Discuss Fiscal Year 2014 Financial Results investment picks
Earnings to be Released before the Market Opens on Wednesday, January 28, 2015 Webcast Scheduled for 8:30 AM ET on Wednesday, January 28, 2015 BERWYN, Pa.
Sign-up for AMETEK Announces Fourth Quarter 2014 Earnings Release and Webcasted Investor Conference Call investment picks
Revenue Growth in Quarter FREMONT, Calif.
Sign-up for Procera Networks Updates Outlook for Fourth Quarter investment picks
Expanding Atmel | SMART Portfolio of SmartConnect Wireless Solutions, Secure, Low-power Wi-Fi With Bluetooth Solutions Deliver High Performance and Lower Overall Bill of Materials for IoT Design Flexibility SAN JOSE, Calif.
Sign-up for Atmel Expands SmartConnect Wireless Portfolio with a Cloud-Ready Wi-Fi/Bluetooth Combo Platform for IoT Applications investment picks
maXStylus mXTS220 Delivers Significantly Improved Active Pen Performance with Longer Battery Life, Higher Noise Immunity and Optimized Design for Lower System Cost for Mobile Devices SAN JOSE, Calif.
Sign-up for Atmel Launches Next Generation maXStylus mXTS220 Active Pen Platform Delivering Extremely Precise Handwriting with an Architecture Built for the Future of Stylus investment picks
Award recognizes the GaN-based 1-kW pulsed power amplifier for excellence in product development ORLANDO, Fla.
Sign-up for API Technologies Wins "Product of the Year" Award from Electronic Products Magazine investment picks
PINGDINGSHAN, China, Jan.
Sign-up for SinoCoking Issues Update on Underground Coal Gasification Project investment picks
2015/1/7
Radian Guaranty Inc., the mortgage insurance subsidiary of Radian Group Inc., today released data for primary mortgage insurance delinquencies for December 2014.
Sign-up for Radian Releases Delinquency Data for December investment picks
SANTA MONICA, Calif., Jan.
Sign-up for Kite Pharma to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/7
Marsh, a global leader in insurance broking and risk management, today announced that it has acquired Aalst-based Trade Insure NV, a leading distributor of credit insurance policies in Belgium.
Sign-up for Marsh Acquires Aalst-Based Trade Insure NV investment picks
Activision Blizzard, Inc. (Nasdaq: ATVI) intends to release its fourth quarter 2014 results after the close of the market on Thursday, February 5, 2015.
Sign-up for Activision Blizzard to Release Fourth Quarter 2014 Financial Results on February 5, 2015 investment picks
2015/1/7
SAN DIEGO , Jan.
Sign-up for Mast Therapeutics To Present At 2015 Biotech Showcase Conference On January 12th investment picks
http://media.marketwire.com/attachments/201412/82894_sphere3d.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167820&ProfileId=051205&sourceType=1 SAN JOSE, CA and MISSISSAUGA, ON --
Sign-up for Sphere 3D Announces Availability of New RDX QuikStor Backup Appliance investment picks
UniFirst Corporation (NYSE: UNF) today announced results for its fiscal 2015 first quarter, which ended November 29, 2014.
Sign-up for UniFirst Announces Financial Results for the First Quarter of Fiscal 2015 investment picks
BEACHWOOD, Ohio , Jan.
Sign-up for DDR Provides 2015 Operating FFO Guidance investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases to DDR Provides 2015 Operating FFO Guidance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent